Opinion

Video

Biomarker Testing in Advanced Endometrial Cancer: Approach, Key Markers, and Impact on Treatment Decisions

Panelists discuss their approach to biomarker testing in advanced endometrial cancer, including the timing and types of testing performed, the specific biomarkers assessed (such as mismatch repair/microsatellite instability, POLE, and TP53), and how these results inform treatment decisions.

Video content above is prompted by the following:

How do you typically approach biomarker testing for advanced endometrial cancer?

  • When do you test/retest, and what type of testing do you perform?
  • Which biomarkers do you generally access (eg, mismatch repair/microsatellite instability, POLE, TP53, etc) and how do results help guide your treatment approach?

Related Videos
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video